Position in JNJ
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$479,449,993
+$130,843,340 QoQ
Shares Held
1,961,422
+16.4% QoQ
Ownership
0.081%
of shares outstanding
% of Portfolio
0.58%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026SEI INVESTMENTS CO holds $2,568,983,951 across 16 Drug Manufacturers - General names. JNJ ranks #2 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
767,347 | $705,782,748 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
1,961,422 | $479,449,993 | |
| 3 | MRK |
Merck & Co., Inc.
|
2,102,456 | $252,904,431 | |
| 4 | ABBV |
AbbVie Inc.
|
884,601 | $192,391,870 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,158,099 | $161,404,257 | |
| 6 | AZN |
Astrazeneca PLC
|
683,752 | $134,849,568 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,199,004 | $133,369,592 | |
| 8 | GSK |
GSK plc
|
2,286,880 | $126,212,906 |
All Filings in JNJ
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $479,449,993 | 1,961,422 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $348,606,653 | 1,684,497 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $281,894,210 | 1,520,301 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $202,533,209 | 1,325,913 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $203,610,224 | 1,227,751 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $175,020,713 | 1,210,211 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $185,109,793 | 1,142,230 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $164,672,332 | 1,126,658 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $160,950,888 | 1,017,453 | Shares | Defined | 2024-05-07 | |
| 2023-12-31 | $145,165,690 | 926,156 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $151,914,187 | 975,372 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $160,434,397 | 969,275 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $159,318,765 | 1,027,863 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $138,141,712 | 782,008 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $150,992,013 | 924,290 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $169,615,241 | 955,525 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $146,308,858 | 825,531 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $145,235,692 | 848,984 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $132,104,415 | 817,984 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $110,960,790 | 673,551 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $97,164,376 | 591,204 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $99,478,165 | 632,089 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $96,291,563 | 646,773 | Shares | Defined | 2020-12-04 | |
| 2020-06-30 | $95,501,128 | 679,095 | Shares | Defined | 2020-08-17 | |
| 2020-03-31 | $91,048,278 | 694,336 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||